Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Jazz Pharmaceuticals PLC gives FY 2013 revenue guidance above analysts' estimates - Conference call


Monday, 13 Jan 2014 01:00pm EST 

Jazz Pharmaceuticals PLC:Says that based on the guidance it gave in Nov. 2013, the company is targeting 50% revenue growth in fiscal 2013 over fiscal 2012.Reported revenue of $585.98 mln in fiscal 2012.Revenue of $874.41 mln for fiscal 2013 - Thomson Reuters I/B/E/S. 

Company Quote

160.56
-1.6 -0.99%
30 Sep 2014